Diabetes

The researchers noted that during high-risk pregnancies, special monitoring and care throughout the pregnancy is mandatory.

Researchers noted decreases in control of blood pressure as well as non¬–high-density lipoprotein cholesterol, both of which are risk factors for diabetes.

The researchers found that the effect of fatigue from sleep disruption increased among patients with diabetes.

Continuous glucose monitors were associated with a decline in levels of HbA1c as well as reduced emergency department visits and hospitalizations for hypoglycemia.

After identifying 3 novel checkpoints involved in immunosuppression and autoimmune diseases, investigators developed recombinant proteins that could be used in this patient population.

Investigators from Monash University determined the prevalence of undiagnosed type 2 diabetes utilizing machine learning to analyze modifiable markers not included in screening guidelines.

By encouraging patients to find activities they enjoy and celebrating small improvements, health care professionals can help patients improve mild to moderate hypertension and elevated cholesterol.

Semaglutide (Wegovy) injection is indicated for use with a reduced calorie meal plan and increased physical activity to help adults with obesity or overweight, who also have weight-related medical problems, lose weight and maintain weight loss.

Semaglutide (Ozempic) is a glucagon-like peptide 1 receptor agonist, approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Researchers at the National Institutes of Health (NIH) found that pregnant women only made slight changes to their diet after a gestational diabetes diagnosis.

Researchers found an association between fruit intake and markers of insulin sensitivity, which meant that people who consumed more fruit had to produce less insulin to lower their blood glucose levels.

Launched in 2020, a diabetes pilot program resulted in a significant improvement in patient outcomes for those enrolled.

Study examines whether implementing an oral care protocol for general practitioners can improve patient-centered outcomes for individuals with type 2 diabetes.

A recent study also found that weight loss may decrease dependence on medication.

In March, the FDA approved dasiglucagon (Zegalogue) for the treatment of severe hypoglycemia in people with diabetes aged 6 years or older.

The new data show that patients were able to benefit from finerenone treatment regardless of AFib history, which indicates that finerenone can reduce the rate of new-onset AFib.

Smart agent systems designed to automate insulin dose selection for critically ill patients could potentially optimize the safety and efficiency of insulin infusion practices in intensive care unit settings, according to a study published in BMJ Quality & Safety.

Pairing semaglutide, a drug used to treat diabetes, with a minimally invasive endoscopic sleeve gastroplasty (ESG) can provide significant weight loss benefits for patients who are not candidates for invasive weight loss surgery, according to a study presented at Digestive Disease Week 2021.

According to the US Department of Health and Human Services Office of Minority Health, Asian Americans are 40% more likely to be diagnosed with diabetes and 60% more likely to be diagnosed with renal disease compared to non-Hispanic whites.

With the creation of a diabetes prevention program, participants are able to make lasting behavioral changes, such as eating healthier, increasing physical activity, and improving problem-solving skills.

When lifestyle changes fail, medication becomes necessary to decrease chances of maternal and newborn complications.

Pharmacists can play a direct role in addressing social disparities of health in low-income communities by building trust and providing expertise to patients.

Because several pharmaceutical companies pulled back from the federal 340B program last fall, many patients with diabetes are now seeing skyrocketing insulin prices, according to Anne Webster, NP, with UnityPoint Health.

The approval of dapagliflozin is the most significant advancement in the treatment of chronic kidney disease in more than 20 years, according to a press release.

A heart rhythm disorder, atrial fibrillation occurs at least twice as frequently in patients with diabetes as those without.